Back

LIS1 is critical for axon integrity in adult mice

Matoo, S.; Ventrone, A. M.; Patel, S.; Otterson, J.; Noonan, S. A.; Leever, N.; Hines, T. J.; Kalinski, A. L.; Smith, D. S.

2026-04-03 neuroscience
10.1101/2025.10.20.683562 bioRxiv
Show abstract

Mutations in human LIS1 cause lissencephaly, a severe developmental brain malformation. Although most stud-ies focus on development, LIS1 is also expressed in adult mouse tissues. We previously induced LIS1 knockout (iKO) in adult mice using a Cre-Lox approach with an actin promoter driving CreERT2 expression. This proved to be rapidly lethal, with evidence pointing toward nervous system dysfunction. CreERT2 activity was observed in astrocytes, brainstem and spinal motor neurons, and axons and Schwann cells in the sciatic and phrenic nerves, suggesting dysfunctional cardiorespiratory and motor circuits. However, it is unclear how LIS1 knockout in these different cell types contributes to the lethal phenotype. We now report that LIS1 depletion from astro-cytes is not lethal to mice (male or female), although glial fibrillary protein (GFAP) expression is increased in all LIS1-depleted astrocytes. In contrast, LIS1 depletion from projection neurons causes motor deficits and rapid lethality in both males and females. This is accompanied by progressive, widespread axonal degeneration along the entire length of both motor and sensory axons. Interestingly, sensory neurons harvested from iKO mice ini-tially extend axons in culture but soon develop axonal swellings and fragmentation, indicating axonal degenera-tion. LIS1 is a prominent regulator of cytoplasmic dynein 1 (dynein, hereafter), a microtubule motor whose dis-ruption can cause both cortical malformations and later-onset neurodegenerative diseases, such as Charcot-Marie-Tooth disease. Our results raise the possibility that LIS1 depletion, through disruption of dynein function in mature axons, may lead to Wallerian-like axon degeneration without traumatic nerve injury.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
eneuro
389 papers in training set
Top 0.8%
7.1%
2
Brain
154 papers in training set
Top 1.0%
6.3%
3
Neurobiology of Disease
134 papers in training set
Top 1%
4.8%
4
Scientific Reports
3102 papers in training set
Top 24%
4.8%
5
Human Molecular Genetics
130 papers in training set
Top 0.5%
4.3%
6
Acta Neuropathologica Communications
81 papers in training set
Top 0.2%
3.9%
7
Disease Models & Mechanisms
119 papers in training set
Top 0.5%
3.6%
8
Brain Communications
147 papers in training set
Top 0.7%
3.6%
9
PLOS ONE
4510 papers in training set
Top 43%
3.0%
10
eLife
5422 papers in training set
Top 29%
3.0%
11
Acta Neuropathologica
51 papers in training set
Top 0.4%
2.9%
12
Nature Communications
4913 papers in training set
Top 44%
2.6%
13
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 26%
2.4%
50% of probability mass above
14
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.3%
2.1%
15
Cell Reports
1338 papers in training set
Top 21%
2.1%
16
Frontiers in Molecular Neuroscience
43 papers in training set
Top 0.2%
2.1%
17
Molecular and Cellular Neuroscience
18 papers in training set
Top 0.1%
2.1%
18
JCI Insight
241 papers in training set
Top 4%
1.7%
19
PLOS Genetics
756 papers in training set
Top 9%
1.7%
20
Frontiers in Neuroscience
223 papers in training set
Top 4%
1.5%
21
The Journal of Neuroscience
928 papers in training set
Top 6%
1.5%
22
Experimental Neurology
57 papers in training set
Top 0.7%
1.5%
23
Frontiers in Neurology
91 papers in training set
Top 4%
1.3%
24
ASN Neuro
10 papers in training set
Top 0.1%
1.3%
25
Journal of Comparative Neurology
66 papers in training set
Top 0.5%
1.2%
26
Genetics
225 papers in training set
Top 3%
1.2%
27
Journal of Biological Chemistry
641 papers in training set
Top 3%
1.2%
28
Journal of Neurology
26 papers in training set
Top 1.0%
0.9%
29
Glia
74 papers in training set
Top 0.4%
0.9%
30
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.5%
0.9%